Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents

Authors


  • T Sutherland MBBS MMed FRANZCR; M Seale MBBS FRANZCR; K Yap MBBS MMed FRANZCR FRACP.
  • Conflict of interest: All authors are in agreement with the text.
  • No conflict of interest.

Summary

Focal nodular hyperplasia (FNH) is the second most common benign liver tumour and typically do not require any treatment. An accurate non-invasive diagnosis is therefore vital to avoid unnecessary intervention and to reassure patients. This article discusses the demographics and pathology of FNH and reviews the appearance of FNH at MRI using liver-specific contrast agents.

Ancillary